FGFR2 and neoplasm: FGFR2 expression was assessed in the primary tumor as well as in several lymph node metastases from the same patients by immunohistochemistry with three different antibodies (Abcam clone EPR24075-418, R&D clone 98706, Santa Cruz clone C-8).